Skip to Main Content

We publish recommendations and resources, together with a host of other material for the benefit of our users.

A digest of NHS Specialist Pharmacy Service support for professionals working in all areas of the healthcare system for August 2026.
SPS PGD template for administering benzylpenicillin prior to transfer to secondary care in suspected bacterial meningitis or meningococcal septicaemia.
A resource collating the latest medication safety communications and publications to inform, support and inspire medication safety improvements.
SPS PGD template for the insertion of the Progestogen-Only Intra-Uterine Device (LNG-IUD) for contraception.
A digest of NHS Specialist Pharmacy Service support for professionals working in all areas of the healthcare system for July 2026.
SPS PGD template for the insertion of etonogestrel (e.g. Nexplanon®) 68mg subdermal implant for contraception.
SPS PGD template for the supply and/or administration of subcutaneous medroxyprogesterone acetate (DMPA) subcutaneous (SC) injection for contraception.
SPS PGD template for the supply of combined hormonal transdermal patch for contraception.
SPS PGD template for the supply of combined hormonal vaginal ring for contraception.
SPS PGD template for the supply of a fluconazole 150mg capsule (single dose) for the treatment of vulvo-vaginal candidiasis.
Our annual output ‘PO’ supports managed entry and budget planning for new medicines, new indications and medicines with loss of exclusivity in the NHS.
A digest of NHS Specialist Pharmacy Service support for professionals working in all areas of the healthcare system for August 2026.
The main legal mechanisms used to supply and/or administer medicines are explained and considerations suggested for the most appropriate option(s)
SPS PGD template for administering benzylpenicillin prior to transfer to secondary care in suspected bacterial meningitis or meningococcal septicaemia.
Examples of medicines known to prolong the QT interval. Medicines are grouped by therapeutic class and are not an exhaustive list.
Guidance on patient assessment and management of medicines associated with QT interval prolongation.
We have provided guidance on the recurrent themes or topics of enquiry raised, to support implementation of the Evergreen assessment process.
An SPS Quality Assurance (QA) bite size learning event on planning and designing new aseptic clean rooms for GMP compliance.
A resource collating the latest medication safety communications and publications to inform, support and inspire medication safety improvements.
Effective use provides assurance that an organisation is aware of the most critical medication safety related information, and acts on this to improve safety
New Medicines News is produced by the SPS Horizon Scanning Service. It highlights recent new product launches and significant medicines regulatory changes.
SPS have developed a template audit tool to support organisations in auditing aspects of PGD development and use.
Advice on the use of Patient Group Directions (PGDs) to supply or administer a medication which is part of a clinical trial, study or pilot
E-learning developed by SPS in partnership with UKHSA, HEE and eLfH to support professionals who use, develop, authorise, review or update PGDs.
A report on the state of the pharmacy technical services workforce in the North of England
A checklist for audits and self-inspections for the holders of wholesale distribution authorisations